Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 update
Background: Methotrexate (MTX) is the first-line drug in the treatment of rheumatoid arthritis (RA) and the most commonly prescribed disease modifying anti-rheumatic drug. Moreover, it is also used as an adjuvant drug in patients under biologic therapies, enhancing the efficacy of biologic agents....
Similar Items
-
Reuma.pt contribution to the knowledge of immune-mediated systemic rheumatic diseases
by: Maria José Santos, et al.
Published: (2017-07-01) -
Portuguese Recommendations for the use of biological therapies in patients with rheumatoid arthritis- 2016 update
by: Catia Duarte, et al.
Published: (2017-04-01) -
Neurological complications in HIV infected patients: a portuguese retrospective study
by: Ana Filipa Polido Amador
Published: (2019) -
Multimorbidity is associated with fragility fractures in women in Portugal
by: Anabela Barcelos, et al.
Published: (2021-04-01) -
A convergência e a (re)configuração das práticas jornalísticas na imprensa
by: Ana Filipa Teixeira de Sousa
Published: (2019)